In this issue:
Nemolizumab for prurigo nodularis
IVIG for improving skin symptoms in dermatomyositis
CV and VTE risks with JAK inhibitors in immune-mediated inflammatory skin diseases
Lirentelimab for refractory indolent systemic mastocytosis
Amlitelimab for AD
AFX and pleomorphic dermal sarcoma: recurrence and metastases
Ivarmacitinib in moderate-to-severe alopecia areata
20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis
Hair loss profiles and ritlecitinib efficacy in alopecia areata
Long-term dupilumab for severe paediatric AD
Please login below to download this issue (PDF)